Search research articles
Contact Us
Filters
Showing results (41-50 of 82) with videos related to
Page
of 9
Sort By:
Iscience
|
July 29, 2025
B- and T cell receptor sequencing elucidates characteristics of lymphocyte depletion by ocrelizumab
Tilman Schneider-Hohendorf, Christian Wünsch, Andreas Schulte-Mecklenbeck, et al.
Journal of Rehabilitation Medicine
|
January 26, 2016
Whole-body vibration therapy in intensive care patients: A feasibility and safety study
Tobias Boeselt, Christoph Nell, Katahrina Kehr, et al.
Frontiers in Human Neuroscience
|
September 30, 2024
Detecting fatigue in multiple sclerosis through automatic speech analysis
Marcelo Dias, Felix Dörr, Susett Garthof, et al.
Clinical Neurology and Neurosurgery
|
September 13, 2020
Ocrelizumab Treatment in Patients with Primary Progressive Multiple Sclerosis: Short-term Safety Results from a Compassionate Use Programme in Germany
Sebastian Rauer, Muna-Miriam Hoshi, Refik Pul, et al.
Journal of the Peripheral Nervous System : JPNS
|
June 21, 2013
Efficacy and safety of Privigen(®) in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study)
Jean-Marc Léger, Jan L De Bleecker, Claudia Sommer, et al.
Plos One
|
October 18, 2016
Afferent Visual Pathway Affection in Patients with PMP22 Deletion-Related Hereditary Neuropathy with Liability to Pressure Palsies
Alexander U Brandt, Elena Meinert-Bohn, Jan Leo Rinnenthal, et al.
Seizure
|
May 4, 2013
Levetiracetam but not valproate inhibits function of CD8+ T lymphocytes
Gang Li, Mareike Nowak, Sebastian Bauer, et al.
Journal of Neurology
|
April 13, 2010
Health-related quality of life in ALS, myasthenia gravis and facioscapulohumeral muscular dystrophy
Yaroslav Winter, Karsten Schepelmann, Annika E Spottke, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 16, 2025
Short- and long-term effects of early versus delayed treatment with ocrelizumab on cerebellar volume loss in patients with RMS and PPMS
Douglas L Arnold, Shannon Kolind, Haz-Edine Assemlal, et al.
Plos One
|
July 14, 2015
Measuring Compounds in Exhaled Air to Detect Alzheimer's Disease and Parkinson's Disease
Jan-Philipp Bach, Maike Gold, David Mengel, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 82) with videos related to
Sort By:
Page
of 9
Iscience
|
July 29, 2025
B- and T cell receptor sequencing elucidates characteristics of lymphocyte depletion by ocrelizumab
Tilman Schneider-Hohendorf, Christian Wünsch, Andreas Schulte-Mecklenbeck, et al.
Journal of Rehabilitation Medicine
|
January 26, 2016
Whole-body vibration therapy in intensive care patients: A feasibility and safety study
Tobias Boeselt, Christoph Nell, Katahrina Kehr, et al.
Frontiers in Human Neuroscience
|
September 30, 2024
Detecting fatigue in multiple sclerosis through automatic speech analysis
Marcelo Dias, Felix Dörr, Susett Garthof, et al.
Clinical Neurology and Neurosurgery
|
September 13, 2020
Ocrelizumab Treatment in Patients with Primary Progressive Multiple Sclerosis: Short-term Safety Results from a Compassionate Use Programme in Germany
Sebastian Rauer, Muna-Miriam Hoshi, Refik Pul, et al.
Journal of the Peripheral Nervous System : JPNS
|
June 21, 2013
Efficacy and safety of Privigen(®) in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study)
Jean-Marc Léger, Jan L De Bleecker, Claudia Sommer, et al.
Plos One
|
October 18, 2016
Afferent Visual Pathway Affection in Patients with PMP22 Deletion-Related Hereditary Neuropathy with Liability to Pressure Palsies
Alexander U Brandt, Elena Meinert-Bohn, Jan Leo Rinnenthal, et al.
Seizure
|
May 4, 2013
Levetiracetam but not valproate inhibits function of CD8+ T lymphocytes
Gang Li, Mareike Nowak, Sebastian Bauer, et al.
Journal of Neurology
|
April 13, 2010
Health-related quality of life in ALS, myasthenia gravis and facioscapulohumeral muscular dystrophy
Yaroslav Winter, Karsten Schepelmann, Annika E Spottke, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 16, 2025
Short- and long-term effects of early versus delayed treatment with ocrelizumab on cerebellar volume loss in patients with RMS and PPMS
Douglas L Arnold, Shannon Kolind, Haz-Edine Assemlal, et al.
Plos One
|
July 14, 2015
Measuring Compounds in Exhaled Air to Detect Alzheimer's Disease and Parkinson's Disease
Jan-Philipp Bach, Maike Gold, David Mengel, et al.
Page
of 9